We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBD
11826
PUT
DELISTED
Diebold Nixdorf Incorporated
DBD
$52K ﹤0.01%
22,700
+800
+4% +$2.98K
XELA
11827
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$52K ﹤0.01%
113
-176
-61% -$191K
BKCH icon
11828
CALL
Global X Blockchain ETF
BKCH
$205M
$51K ﹤0.01%
2,500
-550
-18% -$21.5K
HYFT
11829
PUT
MindWalk Holdings
HYFT
$66.3M
$51K ﹤0.01%
13,100
-8,800
-40% -$44.5K
NEON icon
11830
PUT
Neonode
NEON
$15.3M
$51K ﹤0.01%
+10,000
New +$56.1K
PGEN icon
11831
PUT
Precigen
PGEN
$2.18B
$51K ﹤0.01%
38,100
-1,100
-3% -$1.63K
REE
11832
CALL
DELISTED
REE Automotive
REE
$51K ﹤0.01%
1,453
-630
-30% -$32.2K
UBX
11833
DELISTED
Unity Biotechnology
UBX
$51K ﹤0.01%
9,066
+3,207
+55% +$26.8K
BTRS
11834
PUT
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
$51K ﹤0.01%
+10,200
New +$58.7K
NBEV
11835
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$51K ﹤0.01%
227,573
+150,795
+196% +$57K
INTZ
11836
PUT
DELISTED
INTRUSION INC NEW
INTZ
$51K ﹤0.01%
13,100
+2,500
+24% +$9.73K
GASS icon
11837
StealthGas
GASS
$352M
$50K ﹤0.01%
+15,605
New +$43.6K
KULR icon
11838
PUT
KULR Technology Group
KULR
$122M
$50K ﹤0.01%
4,025
-13
-0.3% -$174
SGLY icon
11839
Singularity Future Technology
SGLY
$4.41M
$50K ﹤0.01%
+117
New +$95.7K
WYY icon
11840
WidePoint Corp
WYY
$94.5M
$50K ﹤0.01%
+20,840
New +$62.6K
ZTEK
11841
Zentek
ZTEK
$77.3M
$50K ﹤0.01%
+27,798
New +$60.8K
MBSC.WS
11842
DELISTED
M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
MBSC.WS
$50K ﹤0.01%
417,982
+1,207
+0.3% +$233
LEGAW
11843
DELISTED
Lead Edge Growth Opportunities, Ltd Warrant
LEGAW
$50K ﹤0.01%
250,000
-63,130
-20% -$15.8K
REVHW
11844
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Warrant.
REVHW
$50K ﹤0.01%
200,001
TSIBW
11845
DELISTED
Tishman Speyer Innovation Corp. II Warrant
TSIBW
$50K ﹤0.01%
412,328
BSQR
11846
CALL
DELISTED
BSQUARE Corporation
BSQR
$50K ﹤0.01%
39,500
+21,800
+123% +$30.9K
AUR icon
11847
PUT
Aurora
AUR
$13.7B
$49K ﹤0.01%
25,600
-12,800
-33% -$47.1K
CHR icon
11848
Cheer Holding
CHR
$3.43M
$49K ﹤0.01%
37
+30
+429% +$36.4K
ELDN icon
11849
CALL
Eledon Pharmaceuticals
ELDN
$288M
$49K ﹤0.01%
+20,000
New +$61K
PWCM
11850
PowerCompute Inc
PWCM
$1.18M
$49K ﹤0.01%
+400
New +$101K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.